Trademark: 79373551
Word
KIRTAMSY
Status
Pending
Status Code
686
Status Date
Tuesday, August 13, 2024
Serial Number
79373551
Mark Type
4
Filing Date
Wednesday, April 12, 2023
Published for Opposition
Tuesday, August 13, 2024
Trademark Owner History
Innate Pharma - Owner At Publication
Classifications
5 Pharmaceutical preparations for the treatment of cancer, immunoproliferative disorders, inflammatory disorders and autoimmune disorders, hematological malignancies, lymphomas, T-cell lymphomas, cutaneous T cell lymphomas, Sezary Syndrome and Mycosis fungoides.
Trademark Events
Jul 6, 2023
Sn Assigned For Sect 66a Appl From Ib
Jul 7, 2023
New Application Office Supplied Data Entered
Jul 11, 2023
Application Filing Receipt Mailed
Jan 9, 2024
Assigned To Examiner
Jan 10, 2024
Non-Final Action (Ib Refusal) Prepared For Review
Jan 25, 2024
Non-Final Action Mailed - Refusal Sent To Ib
Feb 14, 2024
Refusal Processed By Ib
Jul 9, 2024
Approved For Pub - Principal Register
Jul 9, 2024
Correspondence Received In Law Office
Jul 9, 2024
Teas/Email Correspondence Entered
Jul 9, 2024
Teas Response To Office Action Received
Jan 9, 2024
Non-Final Action Written
Jan 25, 2024
Refusal Processed By Mpu
Jul 24, 2024
Notification Of Notice Of Publication E-Mailed
Aug 13, 2024
Published For Opposition
Aug 13, 2024
Official Gazette Publication Confirmation E-Mailed
PKB
LONKIRLO
Trademark Alertz updated from USPTO on 2030-01-24

Trademark Alertz ™ - Twit Solutions PTY LTD 2024 - Privacy Policy - Terms of Use

The information provided on Trademark Alertz is not legal or professional advice. Information may have been obtained from third parties and may contain errors. You must make your own enquiries and seek independent advice from relevant industry professionals before acting or relying on any information from Trademark Alertz. All trade mark information has been obtained from and made publicly available by The United States Patent and Trademark Office (USPTO). Copyright of the trademark data resides with USPTO. www.uspto.gov